These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7114807)

  • 1. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome.
    Dau PC; Denys EH
    Ann Neurol; 1982 Jun; 11(6):570-5. PubMed ID: 7114807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eaton-Lambert myasthenic syndrome: long-term treatment of three patients with prednisone.
    Streib EW; Rothner AD
    Ann Neurol; 1981 Nov; 10(5):448-53. PubMed ID: 6272625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
    Jost WH; Mielke U; Schimrigk K
    Wien Klin Wochenschr; 1991; 103(20):629-32. PubMed ID: 1763511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.
    Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M
    Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electromyographic and histopathological study of the Lambert-Eaton myasthenia syndrome. Apropos of a case].
    Dudognon P; Cathala HP; Fardeau M; Ribabeau-Dumas JL; Labrousse G
    Electrodiagn Ther; 1980; 17(1):32-9. PubMed ID: 7460812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambert-Eaton myasthenic syndrome. Clinical and electrophysiological findings in seven cases.
    Zambelis T; Foutsitzi A; Giannakopoulou A; Poulopoulou K; Karandreas N
    Electromyogr Clin Neurophysiol; 2004; 44(5):289-92. PubMed ID: 15378868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis therapy in myasthenia gravis.
    Dau PC
    Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J; Murray NM
    Neurology; 1984 Apr; 34(4):480-5. PubMed ID: 6322050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.
    Schoser B; Jacob S; Hilton-Jones D; Müller-Felber W; Kubisch C; Claus D; Goebel HH; Vita G; Vincent A; Toscano A; Van den Bergh P
    Neuromuscul Disord; 2009 Mar; 19(3):223-8. PubMed ID: 19208478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of lupus nephritis. A two-year prospective study.
    Doria A; Piccoli A; Vesco P; Vaccaro E; Marson P; De Silvestro G; Ossi E; Gambari P
    Ann Med Interne (Paris); 1994; 145(5):307-11. PubMed ID: 7985937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome.
    Oh SJ; Hatanaka Y; Claussen GC; Sher E
    Muscle Nerve; 2007 Feb; 35(2):178-83. PubMed ID: 17058271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma cascade filtration therapy in a case of subacute cerebellar degeneration associated with Eaton-Lambert type of neuromuscular block].
    Kurahashi K; Abe Y; Kurihara A; Takebe K; Matsunaga M
    Rinsho Shinkeigaku; 1986 Feb; 26(2):137-42. PubMed ID: 3698415
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
    Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
    Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome.
    Tim RW; Sanders DB
    Muscle Nerve; 1994 Sep; 17(9):995-1001. PubMed ID: 8065402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis.
    Rodnitzky RL; Bosch EP
    Muscle Nerve; 1981; 4(6):529-30. PubMed ID: 7311992
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome.
    Deodhar A; Norden J; So Y; Bennett R
    J Rheumatol; 1996 Jul; 23(7):1292-4. PubMed ID: 8823710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.